Oxytocin is expressed in epidermal keratinocytes and released upon stimulation with adenosine 5′-[γ-thio]triphosphate in vitro

Experimental Dermatology

Volumn 21, Issue 7, 2012, Pages 535-537

  Denda, Sumiko ^a,b   Takei, Kentaro ^b   Kumamoto, Junichi ^b   Goto, Makiko ^a,b   Tsutsumi, Moe ^a,b   Denda, Mitsuhiro ^a,b  

^a SHISEIDO RESEARCH CENTER   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

ATP; Keratinocyte; Oxytocin; P2X receptor

Indexed keywords

2',3' O ( 2,4,6 TRINITROPHENYL)ADENOSINE 5' TRIPHOSPHATE; ADENOSINE 5' [GAMMA THIO]TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; CALCIUM; NEUROPHYSIN; NEUROPHYSIN I; OXYTOCIN; PURINERGIC P2X RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL CULTURE; CONTROLLED STUDY; ENZYME RELEASE; EPIDERMIS; EXTRACELLULAR MATRIX; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; KERATINOCYTE; LETTER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN;

ADENOSINE TRIPHOSPHATE; CALCIUM; CELLS, CULTURED; EPIDERMIS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; NEUROPHYSINS; OXYTOCIN;

EID: 84863103761     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2012.01507.x     Document Type: Letter

References (30)

1. Denda M, Nakatani M, Ikeyama K et al. Exp Dermatol 2007: 16: 157-161.
2. Zanello S B, Jackson D M, Holick M F. Ann NY Acad Sci 1999: 885: 85-99.
3. Schauer E, Trautinger F, Koeck A et al. J Clin Invest 1994: 93: 2258-2262.
4. Denda M, Inoue K, Fuziwara S, Denda S. J Invest Dermatol 2002: 119: 1034-1040.
5. Fuziwara S, Inoue K, Denda M. J Invest Dermatol 2003: 120: 1023-1029.
6. Fuziwara S, Suzuki A, Inoue K, Denda M. J Invest Dermatol 2005: 125: 783-789.
7. Brownstein M J, Russel J T, Gainer H. Science 1980: 207: 373-378.
8. Leng G, Caquineau C, Sabatier N. Vitam Horm 2005: 71: 27-58.
9. Ferguson J N, Young L J, Hearn E F et al. Nat Genet 2000: 25: 284-288.
10. Kirsch P, Esslinger C, Chen Q et al. J Neurosci 2005: 25: 11489-11493.
11. Hollander E, Notny S, Hanratty M et al. Neuropsychopharmacology 2003: 28: 193-198.
12. Matthiesen A, Ransjo-Arvidson A, Nissen E, Uvnas-Moberg K. Birth 2001: 28: 13-19.
13. Wikstrom S, Gunnarsson T, Nordin C. Int J Neurosci 2003: 113: 787-793.
14. Padhy B M, Kumar V L. Mediators Inflamm 2005: 00000: 360-365.
15. Işeri S O, Gedik I E, Erzik C et al. Burns 2008: 34: 361-369.
16. Gimpl G, Fahrenholz F. Physiol Rev 2005: 81: 629-683.
17. Assinder S J, Carey M, Parkinson T, Nicholson H D. Biol Reprod 2000: 63: 338-356.
18. Denda S, Inoue K, Denda M, Hibino T. J Dermatol Sci 2010: 57: 108-113.
19. Inoue K, Hosoi J, Denda M. J Invest Dermatol 2007: 127: 362-371.
20. Hu Y, Benedict M A, Ding L, Núñez G. EMBO J 1999: 18: 3586-3595.
21. Reilly W M, Saville V L, Burnstock G. Eur J Phrmacol 1987: 140: 47-53.
22. Baqi Y, Hausmann R, Rosefort C et al. J Med Chem 2011: 54: 817-830.
23. Jin D, Liu H X, Hirai H et al. Nature 2007: 446: 41-45.
24. Denda S, Kumamoto J, Takei K et al. J Invest Dermatol 2012: 132: 69-75.
25. Inoue K, Denda M, Tozaki H et al. J Invest Dermatol 2005: 124: 756-763.
26. Tran J N, Pupovac A, Taylor R M et al. Exp Dermatol 2010: 19: e151-e157.
27. Yang Q, Wu Z Z, Li X et al. Neuropharmacology 2002: 43: 910-916.
28. Cockayne D A, Hamilton S G, Zhu Q M et al. Nature 2000: 407: 1011-1015.
29. Denda M, Denda S. Skin Res Technol 2007: 13: 195-201.
30. Tsutusmi M, Inoue K, Denda S et al. Cell Tissue Res 2009: 338: 99-106.